Sorrisos: OC(CCSC[C@@H]1[C@@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]3[C@H](O)[C@@H](O)[C@H](O[C@@H]4[C@H](O)[C@@H](O)[C@H](O5)[C@@H](CSCCC(O)=O)O4)[C@@H](CSCCC(O)=O)O3)[C@@H](CSCCC(O)=O)O2)[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@@H]7[C@@H](CSCCC(O)=O)O[C@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)[C@@H](O)[C@@H]5O[C@@H]9COP(C%10=CC=CC=C%10)(C%11=CC=CC=C%11)=O)O[C@@H]8CSCCC(O)=O)[C@H](O)[C@H]7O)O[C@@H]6CSCCC(O)=O)O1)=O
Inchi: InChI=1S/C82H119O48PS7/c83-44(84)11-18-132-26-37-68-53(99)61(107)77(117-37)126-70-39(28-134-20-13-46(87)88)119-79(63(109)55(70)101)128-72-41(30-136-22-15-48(91)92)121-81(65(111)57(72)103)130-74-43(32-138-24-17-50(95)96)122-82(66(112)58(74)104)129-73-42(31-137-23-16-49(93)94)120-80(64(110)56(73)102)127-71-40(29-135-21-14-47(89)90)118-78(62(108)54(71)100)125-69-38(27-133-19-12-45(85)86)116-76(60(106)52(69)98)123-67-36(115-75(124-68)59(105)51(67)97)25-114-33-131(113,34-7-3-1-4-8-34)35-9-5-2-6-10-35/h1-10,36-43,51-82,97-112H,11-33H2,(H,83,84)(H,85,86)(H,87,88)(H,89,90)(H,91,92)(H,93,94)(H,95,96)/t36-,37-,38-,39-,40-,41-,42-,43-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-/m1/s1
Analytical method development and validation for the estimation of sugammadex
By Parekh, Hemangi; Chokshi, Parin; Mashru, Rajashree
From Journal of Drug Delivery and Therapeutics (2020), 10(1), 52-59.
Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography/tandem mass spectrometry assay
By de Zwart Marcel A H; ten Bruggencate-Broeders Jolanda; van Hal Henk J M; Megens Rene H J J J; Frasa Helma W L H
From Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2011), 879(19), 1573-86.